EICHOR
● Recruiting
Dietary Fiber to Induce Gut Microbiota-mediated Response to Immunotherapy in Melanoma.
Condition: Melanoma (Skin) Stage IV · Melanoma (Skin Cancer) · Melanoma Metastatic · Sponsor: Radboud University Medical Center
About this study
Previous research has shown that a higher fiber intake may have a beneficial effect on the intestinal health and improve the effectiveness of immunotherapy, but this is not certain. The objective of this double-blinded randomized clinical trial is to analyze, whether increased dietary fiber intake by patients with metastatic melanoma will increase the relative amount of Bifidobacterium, which in turn stimulates immune cell activity and improves the response to immunotherapy.
This description comes directly from the study's public registry record.
Talk to the study team
Kalijn Bol, dr. · +31 243618800 · Kalijn.Bol@radboudumc.nl
Isabel Ossekoppele, MS · Isabel.Ossekoppele@radboudumc.nl
Always discuss trial participation with your own doctor first.
Locations (2)
| Medical Oncology | Nijmegen, Gelderland, Netherlands | Recruiting |
| Universitair Medisch Centrum Groningen | Groningen, Provincie Groningen, Netherlands | Not Yet Recruiting |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07686835